Pharmaceuticals, Biotechnology and Life Sciences
Reduced average 30-day heart failure related costs by $17,753 (p<0.0001) per study subject in FUROSCIX® arm compared to historically matched…
EMERYVILLE, Calif., July 13, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today…
REDWOOD CITY, Calif., July 13, 2021 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive…
Company announcement – No. 46 / 2021 Zealand Pharma A/S – Transaction Under Share Repurchase Program Copenhagen 13 July 2021…
BOSTON, July 13, 2021 (GLOBE NEWSWIRE) — Imara Inc. (the “Company”) (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing…
Initiated Phase 1 trial of lead program NX-2127 in patients with relapsed or refractory B-cell malignancies On track to initiate…
Nordic Oil, a market leader in the European CBD industry, has launched its first ever crowdfunding campaignMUNICH, Germany, July 13,…
ImCheck Publishes Seminal Paper in Cell Reports Elucidating How Butyrophilins Activate Vγ9Vδ2 T cell Function Against Tumor Cells First published…
SpineX’s Proprietary SCONE™ Device Offers New Hope to Families of Children with CP SCONE Device SCONE LOS ANGELES, July 13,…
Infant Bacterial Therapeutics AB (publ) today announced that Marie-Louise Alamaa has been appointed Chief Financial Officer (CFO) effective from August…